Furthermore, the major characteristics making MUC1 an appropriate antibody-based therapeutic target are a significantly increased MUC1 expression within epithelial tumors, an apical-basal polarity loss of tumor cells, and MUC1 expression on a cell surface. Here, MUC1 is linked to neoplasm.